Last reviewed · How we verify

NCT06365749

Genetic Feature of Congenital Hearing Loss in Chinese Population

Not yet recruiting Last updated 15 April 2024
What this trial tests

trial in Congenital Hearing Loss in 50 participants. Not yet recruiting.

Timeline
23 April 2024
Primary endpoint
23 November 2026
23 November 2026

Quick facts

Lead sponsorDan Bing
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment50
Start date23 April 2024
Primary completion23 November 2026
Estimated completion23 November 2026

Conditions studied

Sponsor

Dan Bing

Who can join

Under 6 Months, any sex, with Congenital Hearing Loss or Congenital Deafness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Congenital hearing loss, as well as hearing loss present at birth, is one of the most common chronic conditions in children, with a prevalence of permanent bilateral hearing loss of 2.83 per 1000 children of primary school age, which is mainly caused by genetic factors. The goal of this observational study is to learn about novel causative genes in infants with hearing loss in the Chinese population. The main problem it aims to deal with are: * to present the genetic characteristics of the infant with hearing loss in the Chinese population * to build up a prognostic model base on diverse data. Participants will be asked to receive audiological tests and collection of the peripheral blood sample.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congenital Hearing Loss

Currently open trials in the same condition.

Other Dan Bing trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06365749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing